49 2. DETERMINATION OF THE IPI MEASURE › 2.3. Union interest › 2.3.1. Interest of Union economic operators, Regulation (EU) 2025/1197

In forcesince 19 Jun 2025

Considering the strong global competitive position of Union manufacturers and the presence in the Union market of medical devices from other major exporting countries, if contracting authorities and contracting entities could not procure medical devices originating in the PRC in a specific case due to the IPI measure, they could procure medical devices made either in the Union or originating in other third countries instead. Based on the industry estimates concerning the size of the Union medical devices’ market and the value of imported medical devices from third countries, the current market share of Union medical devices of the total Union consumption of medical devices is estimated at approximately 60 %. Assuming that the market share of the medical devices originating in the PRC potentially affected by the IPI measure (i.e. EUR 1-1,2 billion) would be allocated between Union medical devices and medical devices imported from other third countries in proportion to the current market shares, the Union medical devices producers could potentially capture around 60 % of the procurement volume that would have originated in the PRC in the absence of the IPI measure.